What treatments are available for peritoneal cancer from the colon
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Peritoneal Cancer from Colon Cancer: Treatment Overview
I'd be happy to help you understand the general treatment approaches for this condition. Let me explain how doctors typically think about this situation.
Understanding the Clinical Picture
When colon cancer spreads to the peritoneum (the lining of the abdominal cavity), this is called peritoneal metastasis or metastatic colorectal cancer. Doctors evaluate several factors when planning treatment, including:
- How extensive the peritoneal involvement is
- Overall health and performance status
- Genetic/molecular characteristics of the tumor
- Previous treatments received
General Treatment Approaches
According to NCCN Guidelines for Colorectal Cancer, treatment options for peritoneal metastases typically include:
1. Systemic Chemotherapy
- Standard chemotherapy regimens (like FOLFOX, FOLFIRI, or combinations with targeted drugs)
- Often the first-line approach for widespread peritoneal disease
- May include targeted therapies if specific mutations are present (EGFR inhibitors, anti-VEGF agents)
2. Cytoreductive Surgery + HIPEC
- Cytoreductive surgery (CRS): Surgical removal of visible tumors from the peritoneum and organs
- HIPEC (Hyperthermic Intraperitoneal Chemotherapy): Heated chemotherapy delivered directly into the abdomen during surgery
- This combined approach is used in selected patients with limited peritoneal disease
- Requires specialized centers with expertise in this technique
3. Palliative Care
- Focused on symptom management and quality of life
- Can be combined with other treatments
4. Clinical Trials
- Newer immunotherapy combinations
- Novel targeted approaches
- Participation may be an option to discuss
Important Questions for Your Oncology Team
Since YOUR specific situation requires your doctor's complete evaluation, here are key questions to ask:
- What is the extent of my peritoneal involvement? (This significantly affects treatment options)
- Have genetic tests been done on my tumor? (KRAS, BRAF, MSI/dMMR status affects treatment choices)
- Am I a candidate for cytoreductive surgery with HIPEC? (Not all patients are appropriate candidates)
- What chemotherapy regimen do you recommend for my specific case, and why?
- Are there clinical trials available that match my tumor characteristics?
- What is the goal of treatment—curative intent or palliative? (This shapes the entire approach)
Where to Learn More
- NCCN Guidelines for Colorectal Cancer (free at nccn.org) - Updated regularly with current recommendations
- American Cancer Society - Colorectal cancer section with patient-friendly explanations
- National Cancer Institute (NCI) - Cancer.gov has detailed information on metastatic colorectal cancer
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2